OHSU Knight Cancer Community Symposium
About the symposium
Learn about recent advances in cancer care, research, and programs at OHSU and across Oregon in an engaging and interactive environment at this annual symposium. Join us in-person at the Knight Cancer Research Building in Portland or via Webex.
Who should attend
This hybrid event is designed for clinical cancer care teams, clinical researchers, and staff associated with the OHSU Knight Cancer Institute and those communities. This includes but is not limited to medical oncologists, hematologists, radiation oncologists, surgeons, advanced practice providers, researchers, administrators, clinical leaders, and staff.
Agenda
Time | Description |
---|---|
7:30 a.m. | Registration and Breakfast |
8 a.m. | Welcome |
8:30 a.m. | Updates in the Neuro-Oncology Program |
9:15 a.m. | A deeper dive into Commission on Cancer standards |
10 a.m. | Break |
10:15 a.m. | Multidisciplinary Lung Cancer and Lung Nodule Clinic |
11:15 a.m. | Community Partnership Program |
12:15 p.m. | Lunch |
12:45 p.m. | Advances in Breast Cancer |
1:15 p.m. | GI Cancer Updates |
2:30 p.m. | Break |
2:45 p.m. | Cellular Therapy and Immunotherapy Updates |
3:30 p.m. | Closing |
Accreditation and Credit
Accreditation: The School of Medicine, Oregon Health & Science University (OHSU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: Oregon Health & Science University School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
May 9, 2025

Knight Cancer Research Building and Webex
2720 S. Moody Ave.
Portland, OR 97201
Contact
For questions about this event, email our team: kccsymposium@ohsu.edu.
Event archive
April 26, 2024
View agenda | View speaker bios
____________________________________
If you would like to receive the slides from a presentation, email kccsymposium@ohsu.edu .
Welcome introduction and housekeeping
Jackie Shannon, Ph.D.
Early developments and future directions for multi-cancer early detection using blood-based genomic tests
Nima Nabavizadeh, M.D.
School of Dentistry’s Oral Cancer Research and Clinical Care
Hui Wu, Ph.D.
Dental collaboration with head and neck cancer surgeons (recording and slides are not publicly available)
Dan Petrisor, D.M.D., FACS, FICD
Updates in the management of adrenocortical cancer
James Lim, M.D., FACS
Domains of Quality of Life in Cancer Survivors
Lissi Hansen, Ph.D., RN
Updates on oncolytic virus therapies
Richard Maziarz, M.D.
Education and Health Give Life: Spanish Language Cancer Awareness Campaign
Verónica Vasquez and Camerina Galván, Innovare Communications Group (ICG)
Advancing HPV Information and Education in the African American Community in Portland and Multnomah County
Tamra Hickok, Self Enhancement Inc. (SEI)
Precision in Prostate Cancer: PSMA Imaging and Genetic Testing
Alexandra Sokolova, M.D.
Panelists:
- Sara Matar, M.D., Asante
- Allan Cheng, M.D., DDS, Legacy
- Melissa Moffit, M.D., Legacy
- Ryan Kopp, M.D., Portland VA
- Jen Jane Liu, M.D., OHSU
Updates in perioperative mananagement of pancreas cancer
Flavio Rocha, M.D., FACS, FSSO
Updates in radiation therapy for pancreatic cancer
Aaron Grossberg, M.D., Ph.D.
Wrap Up and Thank You
Flavio Rocha, M.D., FACS, FSSO
2023
Click the links below to view presentations from the 2023 Knight Cancer Network Symposium in PDF format:
Welcome & Knight Cancer Institute Highlights and Vision - A snapshot of the Knight Cancer Institute
Jackie Shannon, Ph.D.
Flavio Rocha, M.D., FACS, FSSO
Peritoneal Surface Malignancy - Relaunching OHSU's HIPEC Program
Divya Sood, M.D.
Enhancing Multi-disciplinary Care of Muscle Invasive Bladder Cancer Patients
Jen-Jane Liu, M.D.
Ovarian Cancer in the Era of Precision Medicine: Update 2023
Tanja Pejovic, M.D., Ph.D.
HCT & CAR T Cell Therapy The Rise of Interventional Cellular Immunology
Richard Maziarz, M.D.
Clinical Trials in the Community: The Power of Partnerships
Tiffani Howard, Ph.D.
Community Partnership Program Funded Projects: Building a Community System of Care for Breast Cancer Patients Across Oregon
Pink Lemonade Project Community Resources Sheet
Susan Stearns, M.B.A., M.A.
Community Partnership Program Funded Projects: Asian Diet and Cancer
Holden Leung, M.S.W.
Gemma Kim, M.S.W., LCSW, RN
ctDNA, Ready for Clinical Practice
Adel Kardosh, M.D., Ph.D.
SBRT for Prostate Cancer
Casey Williamson, M.D., M.A.S.
2022
Click the links below to view presentations from the 2022 Knight Cancer Network Symposium in PDF format:
Prostate Cancer Clinical Genomics
Alexandra Sokolova, M.D.
Advances in Sarcoma: Focus on Clinical Trials
Lara Davis, M.D.
Cervical Cancer Inequities and Latina Women: Moving Beyond Surviving to Thriving
C. Estela Vasquez Guzman, Ph.D.
Cancer Care: The Rapidly Emerging World of Clinical Cellular Immunooncology and How it Can Integrate with Community Practices
Richard Maziarz, M.D.
Updates in Surgical Oncology: Colorectal Cancer
Flavio Rocha, M.D., FACS, FSSO
Colorectal Cancer: A Minimalist Approach
Sandy Fang, M.D., FACS, FASCRS
Farm Share Rx Produce Prescription in the mid-Willamette Valley
Jared Hibbard-Swanson, Ph.D., Farm Share Rx
Wellness Education for Cancer Nutrition Study Results Final Report
Stephanie Polizzi, M.P.H., RD, DipACLM WE CAN
Gen S: The Next Generation of Cancer Survivorship Standards
Andrea Lehman, M.S.W., LCSW, OSW-C
Multi-cancer Early Detection in 2022
Tom Beer, M.D., FACP
Bay Area Hospital and OHSU Knight Cancer Network Manuscript Review: Implementing Low-dose Computed Tomography Lung Cancer Screening in a Rural Community Hospital
Jessica Currier, Ph.D.
2021
Click the links below to view presentations from the 2021 Knight Cancer Network Symposium in PDF format:
Knight Cancer Institute Highlights and Vision for the Future
Shivaani Kummar, M.D., FACP
Understanding Interval Breast Cancers that are Missed by Mammogram Screening
Zhenzhen Zhang, Ph.D., M.P.H., M.Med.
OHSU: Comprehensive Center of Excellence in Lymphatic Disease
Allison Nauta, M.D.
Radiotherapeutic Management of the Axilla in Breast Cancer
Kiri Cook, M.D.
Process Improvement: Assessing Your Risk and Tools for Taking Action
Bailey Buckingham
Caitlin Kapper
Adjunctive Hepatic Arterial Infusion to Convert Patients with Unresectable Liver Cancer to a Resectable Status
Skye Mayo, M.D., M.P.H., FACS
GI Oncology- Meet the Experts and Q&A
Adel Kardosh, M.D., Ph.D.
The Cancer Committee Meeting – How to Create a High Quality, Dynamic Forum
V Liana Tsikitis, M.D., M.B.A., M.C.R.
Melissa Alvarado, M.P.H., CTR
Brachytherapy for Prostate and Gynecologic Cancers: Moving the Needle
Jenna Kahn, M.D
OHSU Pancreatic Cancer Early Detection Surveillance Clinic and the PRECEDE Study
Brett Sheppard, M.D.
Aaron Grossberg, M.D., Ph.D.
Advocacy and Quality Improvement in Pancreatobiliary Cancer
Flavio Rocha, M.D.